This announcement is a separate document:
南华生物：南华生物2023年度计提资产减值准备及核销资产的公告
Landfar Bio-medicine: Announcement of Nanhua Biotech's 2023 Asset Impairment Preparation and Asset Write-off
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.